Robuta

China activity dips, but a government procurement program would benefit local biopharma companies.

Grant Avenue Capital announced it has acquired PatientCare EMS Solutions. PatientCare, founded in 1998 and based in Tyler, Texas, is a...

Investors will get creative to get deals done.

The industry roared back after a pandemic-induced lull in 2020.

Healthcare private equity investment posted a very strong year for deal value and volume, paired with a strong rebound in exits.

Bain’s annual report explores the underlying trends in 2025, including rising investor confidence in market fundamentals in the face of headwinds, the...

To win in this space, investors will need to unlock the returns found in complex deals, reshuffle strategies across sectors and geographies and boost returns...

How can investors gain a foothold, even as the ground shifts beneath their feet?

Discover Quadria Capital, a top private equity firm in India and Singapore, dedicated to advancing healthcare through impactful investments and innovative...

Linden Capital Partners devotes world-class resources to exceptional, developing middle-market healthcare and life science companies. Diligent focus,...

Mar 18, 2025 - With decades of experience in the healthcare industry, PYA assists investors in evaluating financial and operational risks associated with proposed...

Macroeconomic forces and geopolitical dynamics shake healthcare dealmaking and valuations.

Despite the swell of political and media attention to private equity’s role in healthcare, PitchBook reports investment growth in providers has slowed.

After a mild decline in deals, North American healthcare private equity activity has started to bounce back on the strength of favorable underlying trends.

Securing large-check financing grew more difficult as the year wore on.

Bain Partner Kara Murphy discusses the macro and micro forces that will change the investing landscape over the coming decade.

Healthcare private equity investment posted a very strong year for deal value and volume, paired with a strong rebound in exits.

Dmitry Podpolny joins as a partner focusing on healthcare and private equity in London; Mark Disston, an expert in activist investing, joins as a principal in...

Limited partners have embraced mid-market fund managers for their strong returns and industry expertise.

The industry roared back after a pandemic-induced lull in 2020.

How can investors gain a foothold, even as the ground shifts beneath their feet?

Regal Healthcare Capital Partners is a private equity investment firm investing in lower and middle market companies in the healthcare service sector.

Margin expansion, currently a minor factor in returns, is bound to become more important.

As markets buckle under volatility, public-to-private deals marry two high-performing sectors in a union far better equipped to thrive

Healthcare private equity investment posted a very strong year for deal value and volume, paired with a strong rebound in exits.

/PRNewswire/ -- Global healthcare private equity (PE) set a new record in 2025 with an estimated $191 billion in deal value, surpassing the previous peak of...

The notion of healthcare as national defense took hold in 2020, but what are the implications of this mindset? We explore this question with 2021 in mind.

Healthcare attorney John Saran was quoted in a Pensions & Investments article about California Gov. Gavin Newsom's veto of a bill that would have regulated...

At BDO, we cover the signs that a blizzard will occur in healthcare deal activity in 2018 with private equity firms as major players. See our numbers.

Healthcare private equity investment posted a very strong year for deal value and volume, paired with a strong rebound in exits.